Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Brian G. Lloyd Sells 25,000 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) insider Brian G. Lloyd sold 25,000 shares of the business's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $99.50, for a total value of $2,487,500.00. Following the completion of the sale, the insider now directly owns 38,993 shares in the company, valued at $3,879,803.50. This represents a 39.07 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Merit Medical Systems Stock Down 1.7 %

Shares of MMSI traded down $1.78 during mid-day trading on Friday, reaching $99.95. The company's stock had a trading volume of 571,334 shares, compared to its average volume of 582,651. The company has a market cap of $5.88 billion, a price-to-earnings ratio of 49.00, a price-to-earnings-growth ratio of 2.34 and a beta of 0.87. The business has a fifty day moving average of $103.29 and a 200 day moving average of $100.30. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57. Merit Medical Systems, Inc. has a 1 year low of $70.70 and a 1 year high of $111.45.

Wall Street Analyst Weigh In

MMSI has been the subject of a number of research analyst reports. Raymond James upped their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the company an "outperform" rating in a report on Tuesday, December 31st. Piper Sandler reissued an "overweight" rating and set a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a research note on Wednesday, January 29th. Canaccord Genuity Group decreased their price target on shares of Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company cut their price objective on Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a research report on Wednesday, February 26th. Finally, Barrington Research reduced their price objective on Merit Medical Systems from $115.00 to $111.00 and set an "outperform" rating for the company in a research note on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Merit Medical Systems presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.78.

Remove Ads

Hedge Funds Weigh In On Merit Medical Systems

A number of large investors have recently made changes to their positions in MMSI. Vanguard Group Inc. grew its position in Merit Medical Systems by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 6,648,659 shares of the medical instruments supplier's stock valued at $643,058,000 after purchasing an additional 63,314 shares in the last quarter. State Street Corp grew its holdings in shares of Merit Medical Systems by 0.7% during the 3rd quarter. State Street Corp now owns 2,231,701 shares of the medical instruments supplier's stock valued at $220,559,000 after acquiring an additional 15,098 shares in the last quarter. FMR LLC grew its holdings in shares of Merit Medical Systems by 31.6% during the 4th quarter. FMR LLC now owns 2,076,439 shares of the medical instruments supplier's stock valued at $200,833,000 after acquiring an additional 499,193 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in shares of Merit Medical Systems by 2.3% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,633,246 shares of the medical instruments supplier's stock worth $157,968,000 after acquiring an additional 36,489 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Merit Medical Systems by 8.3% during the fourth quarter. Invesco Ltd. now owns 1,535,468 shares of the medical instruments supplier's stock worth $148,510,000 after acquiring an additional 118,142 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company's stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.